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Abstract
Dental microbiota is associated with different types of organisms with 
dentition including humans and is responsible for many oral diseases all over 
the world. Bacteria in a dental biofilm are important also in other diseases, i.e., 
endocarditis, pulmonary fibrosis, and arthritis, and some findings predict the 
connection of dental microbiota with cancerogenesis. Not all oral bacterial 
representatives are pathogenic or potentially pathogenic. Dental biofilm consists 
of numerous different bacteria that may have beneficial characteristics for good 
condition of dental and oral health. Searching for bacteria or their products 
with the beneficial effect is important in the development of new biologically 
based strategies for the prevention or treatment of oral and dental diseases. 
For searching of potential probiotic candidates are useful methods that could 
map phenotypic or genotypic characteristics of studied bacteria. This chapter is 
focused on the spectrum of these basic methods searching for beneficial bacte-
ria and their products.
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1. Introduction
Each form of life on earth needs to obtain water and some substances from 
the external environment for its growth. From viruses to whales, every form of 
life needs some substances. Differences are only in the mechanism of obtaining. 
Many types of organisms on earth for this purpose developed the digestive tract 
with the oral cavity during the evolution. The same mechanism is still on earth 
millions and millions of years. For example, dinosaurs had the same mechanism 
and during evolution developed dentition for good mechanical preparing of eaten 
food like humans today with some differences of course. We can deduct, that the 
dental problems in Jurassic age had the same cause as today if we are thinking about 
mechanical destruction. In the case of special dental diseases, like periodontitis 
or dental caries, the comparing is debatable. Maybe in Jurassic age were also some 
pathogens something like Streptococcus mutans nowadays, which were responsible 
for the destruction of dental enamel in Tyrannosaurus rex. Nowadays problems in 
dental diseases have the same causative mechanism. Many of them are caused by 
the effect of dental biofilm bacteria.
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1.1 Biofilm, dental biofilm
A biofilm comprises any syntrophic consortium of microorganisms in which 
cells stick to each other and often also to a surface. Biofilms are highly organized 
bacterial agglomeration, which diversity is depending on the external and internal 
conditions of together growing bacteria.
Bacterial biofilms are also characteristic of the growth of one type of bacteria, 
i.e. a biofilm of Staphylococcus aureus [1]. Biofilms may form on living or non-
living surfaces and can be founded in natural, industrial, and hospital conditions. 
In humans, a typical exam for biofilm is dental plaque. This microcosm was 
deeply characterized with the help of numerous basic or sophisticated methods 
of research. Microbiology procedures, microscopic techniques, genomic and 
proteomic methods bring new light on new findings in dental plaque (biofilm) 
research.
It is interesting, that the knowledge about dental biofilm from the discoveries of 
Anton van Leeuwenhoek (1632–1723) to today age is still not perfect because we are 
not able to decrease the number of dental diseases in the world [2].
Dental caries and periodontal diseases are the most common diseases in the 
world especially in areas with bad quality of dental medicine and in poor regions of 
the world. On the other side, it is also a disease, which is a wide range presented in 
all countries and all social communities.
Bacterial pathogens founded in dental enamel lesions are many times highly 
pathogenic and cause also systematic diseases like endocarditis, meningitis, pulmo-
nary fibrosis, arthritis, and some findings predict the connection of dental micro-
biota with cancerogenesis [3, 4].
1.2 Dental biofilm bacterial composition
Opinions on the number of bacteria living in the oral cavity vary. It has been 
estimated that about 500 species of bacteria inhabit the oral cavity in humans 
[5]. Molecular-based studies have shown that bacterial communities found in the 
oral cavity are highly complex with about 1000 species and have been shown to 
be the second most complex microbial community in the body after the colon [6]. 
Although the animal microbiocenosis of animals and humans has similar proper-
ties, there are also significant differences in relation to the microbial species and 
the relative proportions of these species in the oral cavity [7]. For example, rodents 
lack gender representatives Peptostreptococcus, Bacteroides (currently Prevotella and 
Porphyromonas), Treponema, Vibrio and Leptotrichia [8]. Oral microbiocenosis 
of dogs is believed to be more diverse than oral microbiocenosis in humans [9]. 
However, bacteria in dental biofilm that are responsible for periodontal infectious 
diseases in humans and animals have been shown to be similar [7].
The microbiota of the dental biofilm differs from the microbiota on the mucosal 
surfaces and the composition of the microbiota of the dental biofilm varies in dif-
ferent anatomical sites. Gingival crevice supplies nutrients to bacteria and has low 
redox potential; therefore, it is colonized predominantly by anaerobic species such 
as Prevotella spp., Veillonella spp. and Fusobacterium spp. In contrast, supragingival 
plaque consists mainly of Gram-positive facultatively anaerobic bacteria, especially 
Streptococcus spp. and Actinomyces spp. The composition of the oral microbiota is 
highly dependent on the clinical condition of the teeth and gingivae. Healthy oral 
plaque contains predominantly facultatively anaerobic Gram-positive species, while 
in periodontal diseases microbiota turns into obligate anaerobic Gram-negative spe-
cies [10]. In the formation of dental biofilm, primarily Gram-positive cocci, especially 
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Streptococcus sanguis and Streptococcus mitis, are involved in primary colonization, 
which colonizes the teeth for the first 4 hours after professional cleansing [11]. 
Other early colonizers include Actinomyces spp., Capnocytophaga spp., Eikenella spp., 
Haemophilus spp., Prevotella spp., Propionibacterium spp., and Veillonella spp. [12]. 
One of the major bacteria that serve as a bridge between early and late oral biofilm 
colonizers is Fusobacterium nucleatum [13]. Although it is an anaerobic bacterium, it 
could tolerate oxygen in the biofilm. This ability allows F. nucleatum to promote the 
growth of other strictly anaerobic bacteria such as Porphyromonas gingivalis [14]. Later 
colonizers are Lactobacillus spp., Porphyromonas spp., Actinobacillus spp., Prevotella 
spp., Eubacterium spp., Selenomonas spp., Tannerella spp., Aggregatibacter and 
Treponema spp. [15, 16]. Which type of bacteria, pathogens or potential beneficial 
members of dental microbiota will be chosen for research depends on the researcher. 
Currently, preparations containing probiotic strains such as: Lactobacillus reuteri 
(BioGaia Prodentis), Bacillus coagulans (Life Extension Advanced Oral Hygiene) and 
Streptococcus salivarius K12 (Bactoral) are available on the market [17–20]. Bacillus 
subtilis in form of tablet [VITALREXTM (VL)] is also used in the treatment of 
periodontal diseases [21]. Depending on the findings of the beneficial effect of living 
bacteria, there is also the possibility to use only their metabolic products for research 
aimed at preventing and treating dental diseases.
2. Recommended methods
2.1 Selection criteria useful for studying of dental biofilm and sample obtaining
In the oral cavity area, it is possible to study apart from dental biofilm also 
other biofilms, i.e. buccal, lingual, prosthesis, filled live or death teeth, soft tissue 
biofilms, etc. Our preferred place for obtaining of dental biofilm samples are sites 
of tooth surfaces close to the salivary duct orifices, because proteins produced in 
saliva could help to form biofilm and calculus. In humans, it is the lingual surface 
of the lower front teeth and decreases towards the third molar teeth. On the upper 
jaw, the supragingival calculus is often formed on the buccal surfaces of the first 
molars [22]. Also, in veterinary patients, supragingival calculus usually accumu-
lates more rapidly and in larger amounts on the buccal surfaces of the upper jaws 
[23]. Places for sampling are variable depending on the anatomical proportion of 
hosts that are used for research as volunteers. Except for humans, it is possible to 
study dental biofilm also on domesticated or wild animals. Important criteria in 
the case of human biofilm are smoke, veganism, celiac disease, age, health condi-
tion, therapy with medication and so on. Each external and internal factor could 
change the composition of biofilm and each human has individual microbiota in 
the mouth. It is better when the group of volunteers has similar dental care  
(a type of toothpaste used) and similar food consumption habits. The selection of 
volunteers should be based on the targeted microbiota from the dental biofilm e.g. 
autochthonous or allochthonous or obtaining of pathogenic bacteria from target 
pathological lesions in the oral cavity, e.g. caries, etc. Autochthonous microbiota 
is isolated from volunteers who starve overnight after carefully brushing their 
teeth. The dental biofilm sample has to be obtained immediately after waking up. 
Volunteers could not eat, drink or brush their teeth before sampling. The composi-
tion of autochthonous or allochthonous microbiota depends on sampling time. If 
sampling takes place during the day, samples also contain allochthonous micro-
biota. Better condition for obtaining samples of autochthonous microbiota is from 
volunteers, which several days do not brush the their teeth.
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2.2 Taking of dental biofilm samples
Samples of dental biofilms are easy to obtain, sampling is very simple, painless 
and noninvasive. Each human volunteer should confirm it with the signed agree-
ment with taking samples, their next processing and provide the data in the anam-
nestic questionnaire concerning GDPR. In the case of domestic animals, dog or cat, 
owners have to agree with the possibility of sample taking and processing.
All things that are needed for the researcher are a sterile syringe needle and a 
sterile Eppendorf tube filled with sterile filtrated PBS commercial produced or 
according https://www.protocolsonline.com/recipes/phosphate-buffered-saline-
pbs/. Cultivation liquid medium can be use for this purpose too.
We provide Brain hearth infusion broth (Merck K GaA Darmstadt, Germany). 
In the case of lactic acid bacteria isolation, we use deMan, Rogosa and Sharpe MRS 
(CONDA S.A, Madrid Spain) broth. The blood agar (Tryptic soy agar (TSA)) with 
5% ram’s blood (BBL, Microbiology Systems, Cockeysville, USA) is often chosen 
as the first medium for the cultivation of bacteria in bacteriology. In case of selec-
tion of major streptococcal species it is good to use Mitis Salivarius Agar (Merck 
K GaA Darmstadt, Germany). The classical cultivation method is at 37.5°C during 
24–48 hours under anaerobic or aerobic conditions, depending on target bacterial 
members of dental biofilm. We provide BD GasPak™ systems (Becton, Dickinson 
and Company) for anaerobic cultivation. The further selection of strains is according 
to the cultivation characteristics of selected colonies. Selected strains could be stored 
in the glycerol stock or Microbank system (Pro Lab Diagnostic). Each isolated strain 
has to be identified for further analysis. We provide MALDI-TOF mass spectrometry 
or Blast n analysis of 16S rRNA sequence for identification. The biochemical tests 
could help with the identification and reveal the characteristics of the tested strain.
2.3 Methods useful for identification of bacterial composition of dental biofilm
For the study of the bacterial community and its composition, it is possible to use 
numerous methods. At first, it needs to be mentioned the classical microbiology. By 
classical bacteriology cultivation methods, we could select different types of culti-
vable bacteria in samples of dental biofilm. For this purpose, we could use different 
types of media, from liquid to solid, from basic to highly specific and selective media. 
Different conditions are also used in aerobic and anaerobic cultivation. The most 
numerous bacterial resident in the dental biofilm has better start line as low repre-
sentative bacteria. On the other hand, the conditions in a cultivation medium could 
bring sometimes better conditions for the growth of former less presented bacteria in 
a tested sample. Due to this problem, it is hard to declare the ratio of different types of 
cultivable bacteria. Colonies forming units (CFU) method could reveal the approxi-
mate ratio of bacteria, but only the cultivable ones. Quantitative real-time PCR is a 
cultivation-independent perfect toll for declaring of the bacterial composition of cul-
tivable, hard cultivable or uncultivable bacteria in tested sample, but it is limited due 
to numbers of selected bacterial groups. Amplicon sequencing is a sensitive method 
that is cultivation independent and good for declaring the composition of all bacterial 
members in the tested sample and it could quantify the ratio between bacterial groups 
[24, 25]. This method is cultivation free and principle is based on the amplification of 
total DNA isolated from the sample and next-generation sequencing (NGS) analysis. 
Big data obtained after sequencing are analyzed in silico.
If we combine the amplicon sequencing method with 16S rRNA identification of 
selected and isolated bacteria, we obtain perfect strategy and tools for confirmation 
of identified cultivable and uncultivable bacteria and also their semiquantitative 
ratio in our sample of dental biofilm.
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It is necessary to know the numbers and ratios of bacteria in the sample because 
it can bring light to physiological or pathological parameters. On the other hand, it 
is hard to study this topic, due to the different bacterial composition of individual 
dental biofilms. Many isolated bacteria are autochthonous and host specific, and 
still found in a dental biofilm of the individuals. Based on these findings we can 
predict approximately similar conditions.
Cultivation, isolation, identification, and storage of the strains are necessary 
steps for deep research of pathogens, potential pathogens, and potentially probiotic 
strains and research of their interaction.
2.4 Classical cultivation necessary step in research
This method is still necessary for valid research of potentially beneficial bacteria 
and their products in dental biofilm. For testing of potential candidates as probiotic 
bacteria from dental biofilm at first, we need to isolate and store it by microbiologi-
cal cultivation techniques. The same goes for pathogenic bacteria. A very important 
step in bacteriology research is the identification of bacteria. Form of growth, 
Gram staining, catalase activity, biochemical parameters are helpful in the analysis 
of solitary bacterial colonies. These methods are in some cases imperfect for the 
exact identification of bacteria. In comparison with the methods mentioned above, 
the sequencing of genes coding 16S RNA or other PCR products and next Blast n 
analysis or MALDI-TOF mass spectrometry identification are more sensitive.
Other growth characteristics as the possibility of growth inhibition of other 
bacteria are helpful in the selection of candidates with the production of bioactive 
substances, especially in the case of biosurfactants, bacteriocins, or bacteriocin-like 
inhibitory substances (BLIS) [26, 27].
The presence of genes coding bioactive substances could be easily detected by 
PCR, but better is to check the possibility of their production at first. For example, 
Streptococcus salivarius inhibition potential against Micrococcus luteus could help 
unfold the production of salivaricin [28]. Streptococcus thermophilus could induce 
cell lysis of Pediococcus acidilactici and reveal the potential of Thermophilin 110 pro-
duction [29]. Generally, if the presence of bacteriocins is detected in tested poten-
tial probiotics by growth inhibition during cultivation with the target organism, 
the next step with the help of cultivation and proteomic methods is the overlaying 
gel test. It can detect the mass size of bacteriocins, i.e. in the case of Lactobacillus 
plantarum or Streptococcus thermophilus or other tested bacteria [29, 30]. Cultivation 
is also necessary to obtain a large volume of bacteriocin for further testing with the 
help of large volume fermentation. If bacteriocins are soluble and are produced in 
cultivation media, flow centrifuge is needed for their isolation. If bacteriocins are 
insoluble it is necessary to use ultracentrifuge in this step. The extraction of bacte-
riocins is an important step in isolation [31]. If we have pure bacteriocins for test-
ing, cultivation is still needed. For example, salivaricin isolated from Streptococcus 
salivarius K12 is active against bacterial species involved in halitosis, by inhibition 
of Micrococcus luteus Il, Streptococcus anginosus T29, Eubacterium saburreum ATCC 
33271 and Micromonas micros ATCC 33270 [28].
Cultivation procedures are needed in case of studying of the capability of the 
other bioactive substances like biosurfactants or exopolysaccharides. These two 
products have antagonist effects. Exopolysaccharides enhance adherence and 
biosurfactants promote disruption of adherence.
It was detected that biosurfactant produced by Lactobacillus reuteri could very 
significantly down-regulate expression of Streptococcus mutans glucosyltransferase 
genes (gtfB, gtfC) and fructosyltransferase gene ftf [32]. These genes are very 
important for the production of exopolysaccharides which are responsible for 
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adherence of oral streptococci [33, 34]. In the case of Streptococcus mutans glucos-
yltransferase genes are responsible for cariogenic activity [35]. These genes are also 
useful for the differentiation of streptococcal candidates which are often difficult to 
differentiate because they have high homologous sequences in the 16S rRNA gene.
3.  Possibility to produce bioactive substances detected in tested potential 
bacterial probiotic candidates by PCR (bacteriocins, biosurfactants, 
and exopolysaccharides)
3.1 Recommended isolation of DNA
The isolation of DNA from bacteria that are difficult to isolate, i.e. lactobacilli 
strains, is performed by the NucleoSpin® Tissue kit (Macherey-Nagel GmbH and 
Co. KG, Düren, Germany) using a lysis solution during overnight incubation at 
95°C. The next steps of DNA isolation are according to the manufacturer’s pro-
cedure. It is possible to use other kits for DNA isolation. It depends on researcher 
choice and routine practice in PCR laboratory. After isolation of DNA it is bet-
ter to verify DNA quality and quantity. We use Nanodrop spectrophotometric 
(Wilmington, Delaware USA) analysis for this purpose.
For quick isolation of DNA it is also possible to use one bacterial colony and 
100 μl DNAzol direct (Molecular research centre Inc. Cincinnati. USA), and heat 
it to 95°C during 15 min for isolation of DNA without measuring of DNA quantity, 
but storage of DNA samples for next analysis is time limited. For storage of DNA 
isolated by both methods we recommended −20°C. The isolation steps are accord-
ing to the manufacturer and specific sample.
For PCR we could use Mastermix: One Taq 2X Master Mix (England Biolabs, 
Ipswich, Massachusetts, USA) and specific primers (Tables 1–3) in concentration 
of 33 μmol at volume 0.6 and 1–2 μl of DNA isolated with help of DNAzol direct.
3.2 Bacteriocins and methods for their detection
A large number of lactic acid bacteria produce bacteriocins that kill other 
microorganisms. Lactobacilli bacteriocins have potential utility as pathogen inhibi-
tors in humans [36]. Also, oral streptococci have their bacteriocins for example 
Streptococcus mutans have mutacin, and Streptococcus salivarius has salivaricin [37, 
38]. There are a number of factors influencing the efficacy of bacteriocins in vivo 
and in situ, including the survival of the production strain, specific activity, and 
animal model and targeted pathogen. However, bacteriocins have a great deal of 
promise to manage various infections and may become an alternative to existing 
antibiotics. Bacteriocins will need to undergo the same rigorous, costly research and 
validation process as all other previously approved therapies used in therapy [26]. 
Recommended conditions for detection of genes coding bacteriocins of some oral 
potential beneficial bacteria by PCR are described in (Table 1).
The researcher could study probiotic or pathogenic bacteria depending of the 
particular relationship to diseases. For example, PCR condition for bacteriocin 
detection from Lactobacillus spp. is mentioned in the publication [46]. Detection 
of genes coding production of bacteriocins is only the start of the research. By this 
method, we could select potential candidates for further research. Inhibition poten-
tial can be detected by preferred sensitive bacterial strain for example like in case 
of Streptococcus salivarius salivaricin the sensitive strain is Micrococcus luteus [28]. 
After confirmation of bacteriocin gene presence in tested isolates, there is still much 
work to be done with purification, fractionation, and isolation of bacteriocins. Not 
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Target gene Primers PCR protocol Product size Source
Streptococcus salivarius
Salivaricin salA
SalAUS 5′GTAGAAAATATTTACTACATACT3′
SalADS 5′GTTAAAGTATTCGTAAAACTGATG3′
95°C, 13 min, 30× (95°C, 30 sec, 55°C, 1 min, 72°C, 1 min) 
72°C, 5 min
338 bp [38–40]
Lactobacillus reuteri glycerol 
dehydrogenase
gldC (reuterin)
GD1f 5′GTTCAGTCCGCCGCATATC3′
GD1r 5′GCCGCTCTTCGTGGATTTC3′
94°C, 5 min, 34× (94°C, 1 min, 58°C, 30 sec, 72°C, 50 sec) 
72°C, 7 min
562 bp [41]
Lactobacillus plantarum
Plantaricin
plaF 5′-GGCATAGTTAAAATTCCCCCC-3′
plaR 5′-CAGGTTGCCGCAAAAAAAG-3′
94°C, 5 min, 30× (94°C 45 sec, 53.2°C, 45 sec, 72°C, 45 sec) 
72°C, 5 min
428 bp [42]
Lactobacillus plantarum
Plantaricin S
plnF 5′-GCCTTACCAGCGTAATGCCC-3′
plnR 5′-CTGGTGATGCAATCGTTAGTTT-3′
94°C, 5 min, 30× (94°C, 45 sec, 62.3°C, 30 sec, 68°C, 
2 min sec) 68°C, 5 min
475 bp [43]
Streptococcus mutans
Mutacin
F 5′-AGTTTCAATAGTTACTGTTGC-3′
R 5′-GCCAAACGGAGTTGATCTCGT-3′
94°C, 5 min, 34× (94°C, 1 min, 58°C, 30 sec, 72°C, 50 sec) 
72°C, 7 min
750/450 bp [44]
Bacillus subtilis
Subtilisin
spaSFwd 
5′CAAAGTTCGATGATTTCGATTTGGATGT3′
spaSRev 5′GCAGTTACAAGTTAGTGTTTGAAGGAA3′
94°C, 5 min, 34× (94°C, 30 sec, 55°C, 30 sec, 65°C, 60 sec) 
65°C, 7 min
722 bp [45]
Bacillus subtilis
Subtilosin
sboAFwd 5′CGCGCAAGTAGTCGATTTCTAACA3′
sboARev R 5′CGCGCAAGTAGTCGATTTCTAACA3′
94°C, 5 min, 34× (94°C, 30 sec, 50°C, 30 sec, 65°C, 60 sec) 
65°C, 7 min
565 bp [45]
Table 1. 
PCR conditions used for the detection of gene coding production of bacteriocins.
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all bacteria which present genes for bacteriocins are also capable inhibit pathogens. 
Some inhibition effects are caused by bacteriocins like inhibitory substances or by 
others active molecules which are waiting to discovered.
3.3 Biosurfactants and methods for their detection
Biosurfactants are naturally produced molecules that demonstrate potentially 
useful properties such as the ability to reduce surface tensions between different 
phases [47]. The release of biosurfactants by adhering microorganisms as a defense 
mechanism against other colonizing strains on the same substratum surface has 
been described previously for probiotic bacteria in the urogenital tract, the intes-
tines, and the oropharynx, but not for microorganisms in the oral cavity [48]. The 
antimicrobial properties observed in dialyzed biosurfactants produced by the tested 
lactobacilli open possibilities for their use against microorganisms responsible for 
oral diseases [49]. Biosurfactants (BS) obtained from Lactobacillus spp. exhibit 
antibiofilm and antiadhesive activity against a broad spectrum of microbes [50]. 
For example, they are active against biofilm formation of Candida albicans [51] or 
Staphylococcus aureus [52]. Biosurfactants produced by the Bacillus subtilis SPB1 
strain (HQ392822) revealed a wide spectrum of actions including antimicrobial 
activity towards multidrug-resistant microorganisms [53, 54]. For the detection of 
biosurfactants production, i.e. in the case of Bacillus subtilis, it is recommended to 
use PCR with the help of specific primers listed in Table 2.
Target gene Primers PCR protocol Product size Source
Bacillus 
subtilis 
surfactin sfp
sfp F 5′ATGAAGATTTACGGAATTTA3′
sfp R 5′TTATAAAAGCTCTTCGTACG3′
95°C, 3 min, 30× 
(95°C, 30 sec, 
50°C, 30 sec, 72°C, 
45 sec) 72°C, 
10 min
675 [55]
Bacillus 
subtilis 
surfactin 
srfAA
srfAA F 5′TCGGGACAGGAAGACATCAT3′
srfAA R 
5′CCACTCAAACGGATAATCCTGA3′
95°C, 3 min, 30× 
(95°C, 30 sec, 
60°C, 30 sec, 72°C, 
30 sec) 72°C, 
10 min
201 [55]
Bacillus 
subtilis 
fengycin fenB
fenB F 
5′CCTGGAGAAAGAATATACCGTACCY3′
fenB R 5′GCTGGTTCAGTT KGATCACAT3′
95°C, 3 min, 30× 
(95°C, 30 sec, 
57°C, 30 sec, 72°C, 
45 sec) 72°C, 
10 min
201 [55]
Bacillus 
subtilis 
fengycin fenD
fenD R 5′GCTGGTTCAGTT KGATCACAT3′
fenD F 5′GGCCCGTTCTCTAAATCCAT3′
95°C, 3 min, 30× 
(95°C, 30 sec, 
60°C, 30 sec, 72°C, 
1 min) 72°C, 5 min
670 [55]
Bacillus 
subtilis iturín 
ituD
ituD F 5′TTGAAYGTCAGYGCSCCTTT3′
ituD R 5′TGCGMAAATAATGGSGTCGT3′
95°C, 3 min, 30× 
(95°C, 30 sec, 
57°C, 30 sec, 72°C, 
32 sec) 72°C, 
10 min
482 [55]
Bacillus 
subtilis iturín 
ituC
ituC F 5′GGCTGCTGCAGATGCTTTAT3′
ituC R 5′TCGCAGATAATCGCAGTGAG3′
95°C, 3 min, 30× 
(95°C, 30 sec, 
58°C, 30 sec, 72°C, 
30 sec) 72°C, 
10 min
423 [55]
Table 2. 
PCR conditions used for the detection of gene coding production of biosurfactants.
9 M
eth
od
s for S
earch
in
g of P
oten
tia
l B
en
eficia
l B
a
cteria
 an
d
 T
h
eir P
rod
u
cts in
 D
en
ta
l B
iofilm
D
O
I: h
ttp
://d
x.d
oi.org/10.5772/in
tech
op
en
.88024
Target gene Primers PCR protocol Product size Source
Str. mutans. Glucosyltransferase gene 
(gtf)
MKD-F 
5′GGCACCACAACATTGGGAAGCTCAGTT3′
MKD-R 5′GGAATGGCCGCTAAGTCAACAGGAT3′
95°C, 13 min, 30× (95°C, 30 sec, 67°C, 1 min, 72°C, 
1 min) 72°C, 5 min
433 bp [60, 61]
Str. salivarius. Glucosyltransferase gene 
(gtf)
MKK-F 5′GTGTTGCCACATCTTCACTCGCTTCG3′
MKK-R 
5′CGTTGATGTGCTTGAAAGGGCACCATT3′
95°C, 13 min, 30× (95°C, 30 sec, 66°C, 1 min, 72°C, 
1 min) 72°C, 5 min
544 bp [60]
Str. oralis. Glucosyltransferase gene (gtf) gtfR MKR-F 5′TCCCGGTCAGCAAACTCCAGCC3′
gtfR MKR-R 5′GCAACCTTTGGATTTGCAAC3′
95°C, 13 min 30× (95°C, 30 sec, 66°C, 1 min, 72°C, 1 min) 
72°C, 5 min
374 bp [60]
Lactobacillus spp. Glucosyltransferase 
gene (gtf)
DexreuV 5′GTGAAGGTAACTATGTTG3′
DexreuR 5′ATCCGCATTAAAGAATGG3′
94°C, 5 min, 31× (94°C, 1 min, 47°C, 1 min, 72°C, 1 min) 
72°C, 10 min
600 bp [62]
Table 3. 
PCR conditions used for the detection of gene coding production of exopolysaccharides.
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Other species producing biosurfactants and condition for their detection are able 
in research papers for example: Lactobacillus paracasei produced biosurfactants with 
anti-adhesive properties [56]. Streptococcus mitis biosurfactants plays a protective role 
in the oral cavity and protects against colonization of saliva-coated surfaces by cario-
genic Streptococcus mutans [48]. Based on Bacillus subtilis SPB1 lipopeptides production 
researcher predict their possibility used in toothpaste formulation [53]. Biosurfactants 
are promising bioactive molecules for oral-related health applications [47].
3.4 Exopolysaccharides and methods for their detection
Lactic acid bacteria are the most frequently mentioned in studies of exopolysac-
charides (EPS) in oral microbiota [57]. Except for lactobacilli, which are partici-
pated in the later stages of dental biofilm formation, streptococci are one of the 
first bacteria capable of producing EPS. Streptococci are able to assert themselves 
and adhere to the hard tissues of the oral cavity immediately after washing the 
teeth. This property of adherence is predetermined and is encoded in genes that are 
also responsible for the production of glucosyltransferases. Glucosyltransferases 
(Gtfs) are produced by several types of lactic acid bacteria [58]. Gtfs are generally 
characterized as Gtf-S (glucosyltransferase-soluble) or Gtf-I (glucosyltransferase-
insoluble) enzymes, depending on whether the glucan they produce is water soluble 
or insoluble [59]. For detection of exopolysaccharides production in oral lactic acid 
bacterial members is useful PCR with help of specific primers see in Table 3.
4. Testing of growth inhibition activity against pathogens
Testing of bacterial isolates as potential beneficial candidates or their products 
is necessary step in new discoveries. We are able declarate production of bioactive 
substance by very easy PCR reactions, as mentioned above in part 3. Activity of 
these substances is easy to declare by simply in vitro tests. At first for activity it is 
possible to use spot on or disc diffusion test. Same mechanism of declaration is for 
live bacteria isolates as for isolated bioactive substances.
If we found bacteria with interesting effect in spot or disc diffusion test it 
predict selection criteria of former characterized bacteria for next research.
4.1  The disc diffusion method for Lactobacillus reuteri for testing of growth 
inhibition activity against pathogens
We recommend the disc diffusion test for the detection of the inhibitory proper-
ties of beneficial microorganisms. Selected lactobacilli strains were grown on MRS 
agar (CONDA S.A, Madrid Spain) for 48 hours. anaerobically (Gas Pak Plus, BBL, 
Microbiology Systems, Cockeysville, USA) at 37°C. Then, a standardized suspen-
sion with an optical density of 1 McFarland by dissolving several solitary colonies in 
5 ml of physiological saline was prepared. Sterile clean discs (6 mm diameter, BBL, 
Cockeysville, USA) were placed on Petri dishes (Ø 90 mm) with 20 ml of PYG agar 
(HiMedia Laboratories GmbH Einhausen, Germany). The sterile paper discs were 
inoculated with 5 μl of standardized suspensions of lactobacilli.
As a negative control, one Petri dish with PYG agar is served with a clean paper 
discs soaked with sterile MRS broth.
The plates with discs were incubated for 48 hours. anaerobically (Gas Pak Plus, 
BBL, Microbiology Systems, Cockeysville, USA) at 37°C. The discs were removed 
with a sterile syringe needle or tweezer after incubation. Subsequently, 3 ml of 0.7% 
PYG agar was inoculated with 0.3 ml of the indicator pathogenic strain and put into 
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plates with lactobacilli. Pathogenic strains were incubated for 18 hours in PYG broth 
at 37°C. The plates with YPG medium inoculated with pathogen were incubated for 
24 hours aerobically at 37°C. After incubation, the diameter of the inhibition zones 
was measured. The results were recorded in the table as the arithmetic means of the 
three measurements ± standard deviation.
4.2  The disc diffusion method for Streptococcus salivarius for testing of growth 
inhibition activity against pathogens
The disc diffusion test with Micrococcus luteus was used for the preliminary 
testing of Streptococcus salivarius inhibition [39]. This test analyses the activity of 
the BLIS produced in agar and determines the activity spectrum of Sal9 producers. 
Briefly, the tested strain was inoculated across the surface of the Blood agar medium 
(BBL, Microbiology Systems, Cockeysville, USA) in a glass Petri dish (Ø 90 mm) as 
a 1 cm-wide streak. After incubation, the strain growth was stopped by its exposure 
to chloroform vapor for 30 min. The plate was then aired for 15 min before 24 hours 
inoculating cultures as the indicator strains across the original tested strain. The 
plate was incubated for 24 hours and examined for the zones of the indicator strain 
growth inhibition. The inhibition activity against the selected standard indicators 
was recorded in code form by inoculating the indicators in three triplets. The inhibi-
tion of the first member of a triplet was given a score of 4, the second a score of 2, 
and the third a score of 1. The absence of the inhibitory action against an indicator 
was scored as 0. The code was recorded as a sequence of three numbers representing 
the sum of each triplet. All tests were performed in duplicate, and further testing 
was undertaken until the consistency of the inhibition patterns was obtained [63].
5. Conclusion
It is necessary to know the composition of the dental biofilm of healthy indi-
viduals and the bacterial composition in pathological conditions to identify species 
responsible for disease initiation and progression. Identification of species and their 
characterization is essential for the selection of pathogenic, potentially pathogenic 
and potentially probiotic species. Blast n analysis of 16S RNA or MALDI-TOF mass 
spectrometry identification is perfect tools for identification of bacterial species. 
The ability to modulate the microbiocenosis of the dental biofilm by bacteria living 
together in the biofilm should be studied. The some bacteria are capable of produc-
ing bioactive substances whose presence we can quickly and easily declare with 
help of PCR. Sequencing and comparing of genes coding bioactive substances can 
uncover differences between tested bacteria isolates. Presence of these genes and 
prove the ability to inhibit the growth of other bacterial species are important steps 
in selection of potentially probiotic candidates. These bacteria are of great inter-
est for further study and may be useful in the development of new antibacterial 
agents. Bioactive substances can be extracted by physical methods (centrifugation, 
separation and fractionation), by chemical methods (purification) and detected 
by modern analytical method (HPLC) or proteomic methods (MALDI-TOF MS). 
Next important step is declaration of activity pure extracted substance. Bioactive 
substances of bacterial origin can be used in dental preparations and serve as 
prevention or supplementary therapy of periodontal diseases. During recent years 
there has occurred a shift towards ecological and microbial community based 
approach to the therapy of oral cavity diseases. With the increasing resistance to 
antibiotics, the use of probiotics appears as a prospective alternative treatment or 
preventative measure in the control of periodontal diseases. From the clinical point 
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of view, it is not yet possible to give direct recommendations for the use of probiot-
ics. However, the available scientific evidence indicates that probiotic therapy is a 
promising approach also in the field of stomatology. The potential beneficial strains 
of Streptococcus salivarius or Lactobacillus reuteri and others bacterial strains isolated 
from many oral biofilms can be selected for next research based on their produc-
tion of bioactive substances and on growth inhibition level against oral pathogenic 
bacteria not only in human but also in social animals like dogs and cats.
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